The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Oral Vaccines market size is expected to reach US$ 3333.6 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Vaccines in various end use industries. The expanding demands from the Public and Private, are propelling Oral Vaccines market. Rotavirus Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cholera Vaccine segment is estimated at % CAGR for the next seven-year period.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Vaccines covered in this report include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.
The global Oral Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Oral Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Vaccines market, Segment by Type:
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Global Oral Vaccines market, by Application
Public
Private
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Oral Vaccines market size is expected to reach US$ 3333.6 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Vaccines in various end use industries. The expanding demands from the Public and Private, are propelling Oral Vaccines market. Rotavirus Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cholera Vaccine segment is estimated at % CAGR for the next seven-year period.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Vaccines covered in this report include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.
The global Oral Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Oral Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Vaccines market, Segment by Type:
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Global Oral Vaccines market, by Application
Public
Private
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oral Vaccines Market Overview
1.1 Oral Vaccines Product Overview
1.2 Oral Vaccines Market Segment by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Oral Polio Vaccine
1.3 Global Oral Vaccines Market Size by Type
1.3.1 Global Oral Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oral Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oral Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oral Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oral Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oral Vaccines Sales Breakdown by Type (2018-2023)
2 Global Oral Vaccines Market Competition by Company
2.1 Global Top Players by Oral Vaccines Sales (2018-2023)
2.2 Global Top Players by Oral Vaccines Revenue (2018-2023)
2.3 Global Top Players by Oral Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Oral Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Vaccines Market Competitive Situation and Trends
2.5.1 Oral Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Vaccines Market
2.8 Key Manufacturers Oral Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Vaccines Status and Outlook by Region
3.1 Global Oral Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Vaccines Historic Market Size by Region
3.2.1 Global Oral Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Oral Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Oral Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oral Vaccines Forecasted Market Size by Region
3.3.1 Global Oral Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Vaccines by Application
4.1 Oral Vaccines Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Oral Vaccines Market Size by Application
4.2.1 Global Oral Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oral Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oral Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oral Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oral Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oral Vaccines Sales Breakdown by Application (2018-2023)
5 North America Oral Vaccines by Country
5.1 North America Oral Vaccines Historic Market Size by Country
5.1.1 North America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Oral Vaccines Sales in Value by Country (2018-2023)
5.2 North America Oral Vaccines Forecasted Market Size by Country
5.2.1 North America Oral Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Vaccines Sales in Value by Country (2024-2029)
6 Europe Oral Vaccines by Country
6.1 Europe Oral Vaccines Historic Market Size by Country
6.1.1 Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Oral Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Oral Vaccines Forecasted Market Size by Country
6.2.1 Europe Oral Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Vaccines by Region
7.1 Asia-Pacific Oral Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oral Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oral Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Vaccines Sales in Value by Region (2024-2029)
8 Latin America Oral Vaccines by Country
8.1 Latin America Oral Vaccines Historic Market Size by Country
8.1.1 Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oral Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Oral Vaccines Forecasted Market Size by Country
8.2.1 Latin America Oral Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Vaccines by Country
9.1 Middle East and Africa Oral Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oral Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oral Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Oral Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Oral Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Oral Vaccines Products Offered
10.3.5 Sanofi Recent Development
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Company Information
10.4.2 Lanzhou Institute Introduction and Business Overview
10.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lanzhou Institute Oral Vaccines Products Offered
10.4.5 Lanzhou Institute Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute Oral Vaccines Products Offered
10.5.5 Serum Institute Recent Development
10.6 Valneva
10.6.1 Valneva Company Information
10.6.2 Valneva Introduction and Business Overview
10.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Valneva Oral Vaccines Products Offered
10.6.5 Valneva Recent Development
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Company Information
10.7.2 Shanghai United Cell Introduction and Business Overview
10.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shanghai United Cell Oral Vaccines Products Offered
10.7.5 Shanghai United Cell Recent Development
10.8 Bibcol
10.8.1 Bibcol Company Information
10.8.2 Bibcol Introduction and Business Overview
10.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bibcol Oral Vaccines Products Offered
10.8.5 Bibcol Recent Development
10.9 PaxVax
10.9.1 PaxVax Company Information
10.9.2 PaxVax Introduction and Business Overview
10.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 PaxVax Oral Vaccines Products Offered
10.9.5 PaxVax Recent Development
10.10 Vabiotech
10.10.1 Vabiotech Company Information
10.10.2 Vabiotech Introduction and Business Overview
10.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Vabiotech Oral Vaccines Products Offered
10.10.5 Vabiotech Recent Development
10.11 Tiantan Biological
10.11.1 Tiantan Biological Company Information
10.11.2 Tiantan Biological Introduction and Business Overview
10.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Tiantan Biological Oral Vaccines Products Offered
10.11.5 Tiantan Biological Recent Development
10.12 EuBiologics
10.12.1 EuBiologics Company Information
10.12.2 EuBiologics Introduction and Business Overview
10.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 EuBiologics Oral Vaccines Products Offered
10.12.5 EuBiologics Recent Development
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Company Information
10.13.2 Panacea Biotec Ltd Introduction and Business Overview
10.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Panacea Biotec Ltd Oral Vaccines Products Offered
10.13.5 Panacea Biotec Ltd Recent Development
10.14 Bio-Med
10.14.1 Bio-Med Company Information
10.14.2 Bio-Med Introduction and Business Overview
10.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Bio-Med Oral Vaccines Products Offered
10.14.5 Bio-Med Recent Development
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Company Information
10.15.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Products Offered
10.15.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Vaccines Industrial Chain Analysis
11.4 Oral Vaccines Market Dynamics
11.4.1 Oral Vaccines Industry Trends
11.4.2 Oral Vaccines Market Drivers
11.4.3 Oral Vaccines Market Challenges
11.4.4 Oral Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Vaccines Distributors
12.3 Oral Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
